SCHEMBL3785992

SCHEMBL3785992

COc1cccc(N)c1-c1cccc(N)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.48
TDP1 Q9NUW8 2/20 0.48
ADRA2B P18089 1/20 0.48
PTGS1 P23219 1/20 0.48
CYP3A4 P08684 2/20 0.46
HTR1A P08908 2/20 0.44
HTR7 P34969 2/20 0.44
MAOA P21397 1/20 0.44
FYN P06241 1/20 0.43
MAP4K4 O95819 1/20 0.42
CYP19A1 P11511 1/20 0.41
TSHR P16473 1/20 0.41
HSD17B10 Q99714 1/20 0.41
HSP90AA1 P07900 1/20 0.41
HSP90AB1 P08238 1/20 0.41
KIT P10721 1/20 0.40
ABL1 P00519 1/20 0.40
FLT3 P36888 1/20 0.40
MAPT P10636 2/20 0.40
MEN1 O00255 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3789398 0.83 ALDH1A1 (0.59) ALDH1A1TDP1ADRA2BPTGS1CYP3A4
SCHEMBL3785707 0.81 ALDH1A1 (0.52) ALDH1A1TDP1ADRA2BPTGS1CYP3A4
SCHEMBL3784523 0.81 ALDH1A1 (0.53) ALDH1A1CYP3A4MAOAMAP4K4TSHR
SCHEMBL30816756 0.80 ALDH1A1 (0.65) ALDH1A1TDP1ADRA2BPTGS1CYP3A4
SCHEMBL7276398 0.80 ALDH1A1 (0.65) ALDH1A1TDP1ADRA2BPTGS1CYP3A4
SCHEMBL18605215 0.79 CTSA (0.48) ALDH1A1CYP3A4HTR1AHTR7FYN
SCHEMBL3790372 0.79 SMN1; SMN2 (0.43) ALDH1A1TDP1PTGS1HTR1AMAOA
SCHEMBL3789550 0.78 MAOB (0.53) ALDH1A1CYP3A4MAOAMAPTMEN1
SCHEMBL6011357 0.77 ALDH1A1 (0.47) ALDH1A1TDP1ADRA2BPTGS1CYP3A4
SCHEMBL30839730 0.77 ALDH1A1 (0.47) ALDH1A1TDP1ADRA2BPTGS1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2010-04-08 US disclosed
EP-1914221-A1 PROCESS FOR PRODUCING BIARYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-04-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND NISCH, BLVRB, BBOX1 ALDH1A1 4339/4885TDP1 4196/4885ADRA2B 2587/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.